NITROGEN, NF
Clinical safety rating: caution
Comprehensive clinical and safety monograph for NITROGEN, NF (NITROGEN, NF).
Inert gas; displaces oxygen in pulmonary alveoli, leading to hypoxia and asphyxiation. No direct pharmacological activity.
| Metabolism | Not metabolized; excreted unchanged via exhalation. |
| Excretion | Nitrogen (N2) is an inert gas. It is not metabolized. >99% is eliminated unchanged via exhalation through the lungs. Trace amounts may be excreted via skin and feces. Renal excretion is negligible. |
| Half-life | The terminal elimination half-life of nitrogen from body tissues is approximately 4-6 hours after breathing ambient air, reflecting the slow washout from poorly perfused tissues (e.g., fat). In decompression sickness, half-life may be prolonged due to gas bubble dynamics. |
| Protein binding | 0% (Nitrogen does not bind to plasma proteins). |
| Volume of Distribution | Approximately 0.5 L/kg at equilibrium, reflecting total body water distribution. However, nitrogen is more soluble in fat; effective Vd in adipose tissue is higher (~2.5 L/kg). |
| Bioavailability | Inhalation: 100% (absorbed across alveolar-capillary membrane). Oral: 0% (not absorbed). Intravenous: 100% (direct vascular administration). |
| Onset of Action | Inhalation: Rapid distribution within seconds. Clinical effect (e.g., inert gas narcosis at hyperbaric pressures) occurs within minutes of exposure. Intravenous administration (e.g., gas embolism) produces immediate mechanical obstruction. |
| Duration of Action | Duration depends on tissue saturation. For a single breath of 100% nitrogen, effects (e.g., hypoxia) last until oxygen is restored. In decompression, nitrogen elimination half-life dictates duration of risk (hours). Clinical symptoms from gas embolism may persist until bubble resorption (hours to days). |
Not applicable. Nitrogen (N2) is an inert gas not used for therapeutic dosing. As NF grade, it is used as an inert atmosphere or propellant; no standard dose.
| Dosage form | GAS |
| Renal impairment | Not applicable. No dose adjustment required as nitrogen is not renally cleared. |
| Liver impairment | Not applicable. No dose adjustment required as nitrogen is not hepatically cleared. |
| Pediatric use | Not applicable. No established pediatric dosing for therapeutic use. |
| Geriatric use | Not applicable. No specific considerations for elderly patients. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for NITROGEN, NF (NITROGEN, NF).
| Breastfeeding | No data on excretion into human milk; M/P ratio unknown. Consider alternative agents due to lack of safety data. |
| Teratogenic Risk | FDA Category X. First trimester: No known risk at atmospheric pressure. Under hyperbaric conditions, potential for teratogenicity due to oxidative stress. Second and third trimesters: No known adverse fetal effects at normobaric doses. |
| Fetal Monitoring |
■ FDA Black Box Warning
Not applicable; not FDA-approved for medical use.
| Serious Effects |
None established; not intended for human medical use.
| Precautions | Extremely hazardous; can cause rapid asphyxiation due to oxygen displacement. Use only in well-ventilated areas. Avoid skin contact with liquid nitrogen to prevent frostbite. |
Loading safety data…
| Monitor maternal blood nitrogen levels during hyperbaric therapy. Fetal heart rate monitoring during prolonged exposure in pregnancy. |
| Fertility Effects | No known effects on fertility at normobaric concentrations. |